AIOS

Sign in

Open roles

  • AIOS logo
    Senior Security Engineer at AIOS — Remote, $150k–$250k/yr inc equity

    AIOS

    • Remote (US)
    • Remote · Senior
    • $150k–$250k
    No visa sponsorshipAI-native
    Y Combinator
    Posted today
  • AIOS logo
    Web Designer at AIOS — Remote, $100k-$200k/yr (including equity)

    AIOS

    • Remote (US)
    • Remote · Mid-level
    No visa sponsorshipAI-native
    Y Combinator
    Posted today
  • AIOS logo
    Product Manager - Engagement — Remote, $150k-300k/yr inc equity

    AIOS

    • Remote (US)
    • Remote · Senior
    • $150k–$300k
    No visa sponsorship
    Y Combinator
    Posted 4d ago
  • AIOS logo
    AI Engineering Lead at AIOS — Remote, $200-$400k/yr + equity

    AIOS

    • Remote (US)
    • Remote · Senior
    • $200k–$400k
    No visa sponsorshipZero to oneAI-native
    Y Combinator
    Posted 4d ago
  • AIOS logo
    Media Buyer (Paid Search) at AIOS — Remote, $150k–$300k/yr inc equity

    AIOS

    • Remote (US)
    • Remote · Senior
    No visa sponsorship
    Y Combinator
    Posted 4d ago
  • AIOS logo
    Talent Lead at AIOS- Remote, $100-200k inc equity

    AIOS

    • Remote (US)
    • Remote · Senior
    • $100k–$200k
    No visa sponsorship
    Y Combinator
    Posted 4d ago
Show all roles

About

AIOS logo

AIOS

The world's first full-stack AI doctor.

AIOS is building the world’s first full-stack AI doctor. We’re at $450M ARR, growing from $7M/yr in April 2025. We’re faithfully serving 200k/mo patients via Bolt Pharmacy, our main UK brand. We’ve just launched Bolt Med, our international brand. We’re profitable. Our strategy exists at the intersection of two strong theses: 1. The AI doctor that wins will get to escape velocity using GLP-1s, the fastest growing consumer product in history. 2. The $2T European healthcare market is overlooked by the most talented builders. Our master plan: Step 0 → $100M/yr by end of 2025: We went from $10M to $100M in 6 months serving the UK GLP-1 market. Step 1 → $1B ARR by end of 2026: Since April 2025 we've grown from 3k to 200k UK active GLP-1 patients. We’ll continue this growth curve to hit $1B ARR. Step 2 → $10B ARR by end of 2028: Blitzscale Europe. We’ll be Europe’s largest GLP-1 provider. Step 3 → $100B/yr by end of 2030: Get regulatory approval across Europe for our Full Autonomous Prescr

Private companyYC W20$100M+ ARRAI-product
Profitable
Founded2021
HQSan Francisco, United States
Size51–200 employees
IndustryTechnology, Information and Internet

Claim aiosmedical.com

Work at aiosmedical.com? Sign in to claim this org and manage its profile.

ThesisExploreTermsPrivacy
© 2026 Saywise Inc.